<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Hematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann. Hematol</journal-id>
      <journal-title-group>
        <journal-title>Annals of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0939-5555</issn>
      <issn pub-type="epub">1432-0584</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22992981</article-id>
      <article-id pub-id-type="pmc">3567328</article-id>
      <article-id pub-id-type="publisher-id">1577</article-id>
      <article-id pub-id-type="doi">10.1007/s00277-012-1577-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Paraneoplastic disseminated lentigines heralding aggressive Langerhans cell sarcoma</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Au</surname>
            <given-names>Wing Y.</given-names>
          </name>
          <address>
            <phone>+852-28018628</phone>
            <fax>+852-28015638</fax>
            <email>auwing@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lai</surname>
            <given-names>Chris</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Trendell-Smith</surname>
            <given-names>Nigel J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ng</surname>
            <given-names>Wai-Man</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chow</surname>
            <given-names>Donna L. S. N.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <aff id="Aff1"><label/>Blood-Med Hematology Center, Hong Kong, People&#x2019;s Republic of China </aff>
        <aff id="Aff2"><label/>Department of Pathology, Baptist Hospital, Hong Kong, People&#x2019;s Republic of China </aff>
        <aff id="Aff3"><label/>Department of Pathology, Queen Mary Hospital, Hong Kong, People&#x2019;s Republic of China </aff>
        <aff id="Aff4"><label/>Pedder Surgical Group, Hong Kong, People&#x2019;s Republic of China </aff>
        <aff id="Aff5"><label/>Hong Kong Pacific Cancer Centre, Hong Kong, People&#x2019;s Republic of China </aff>
        <aff id="Aff6"><label/>1108 Crawford House, 70 Queen&#x2019;s Road Central, Hong Kong, People&#x2019;s Republic of China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>9</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>20</day>
        <month>9</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2013</year>
      </pub-date>
      <volume>92</volume>
      <issue>3</issue>
      <fpage>419</fpage>
      <lpage>420</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>7</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>8</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2012</copyright-statement>
      </permissions>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag Berlin Heidelberg 2013</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Dear Editor,</p>
    <p>A 21-year-old man presented with a rapidly growing (9&#xA0;cm), non-tender right flank mass with superficial excoriation and inflammation (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>). The lesion was accompanied by rapid onset of disseminated brown papules, involving the torso, back, and limbs (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>). Facial and axillary skins were spared, and there was no particular direction of spread. The skin patches did not coalesce or show pruritus or inflammation. There was also weight loss of 15&#xA0;lb in 3&#xA0;months. A positron emission tomogram scan (PET) showed FDG uptake in the right waist (SUV 5.8) and right groin (SUV 2.1) (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>). Wide margin resection of the mass and lymph node excision was performed with clear margins. Histology of both specimens showed sheets and loose clusters of pleomorphic malignant cells infiltrating the dermis and subcutis with frequent mitosis (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>). In view of the anaplastic morphology and unusual presentation, extensive immunophenotyping was performed. The cells were positive for CD1a, S100, and Langerin stains. They were negative for melanocytic markers (HMB45, melan-A, MITF) EMA, cytokeratin (CK, Cam 5.2, 34betaE12), actin, desmin, CD31, CD34, c-kit, B and T markers (CD20, CD79a, CD3), CD68, CD30, CD56, CD21, MPO, and ALK1. Electron microscopy for Birbeck granules was not performed. The picture was compatible with Langerhans cell sarcoma (LCS). A separate skin biopsy of a pigmented lesion on the torso showed elongated rete ridges with increased basal melanin pigmentation within keratinocytes and the tips, with no increased Langerhans cells and no evidence of malignancy or dysplasia. The lesion was compatible with common lentigo. The patient was treated with consolidation radiotherapy to the primary sites, but there was no regression of the skin lentiges.<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>a</bold> Clinical photo showing the flank mass with impending ulceration. <bold>b</bold> Widespread lentiginous lesion all over the trunk heralding the rapid growth of the malignant lesion. <bold>c</bold> PET with maximum intensity projection showing two sites of active lesions in the flank and in the right groin lymph node. <bold>d</bold> Histology of the lesion showing sheets of pleomorphic tumor cells with indented or lobulated nuclei, moderate to severe nuclear pleomorphism, distinct nucleoli, and moderate pale eosinophilic or amphophilic cytoplasm. Occasional multinucleated cells are present, and mitotic count is frequent. (H&amp;E, &#xD7;400 magnification). <bold>e</bold> The tumor cells are positive for CD1a stain. (Immunotech 1:20, &#xD7;400 magnification). <bold>f</bold> The tumor cells are positive for Langerin stain with cytoplasmic granular staining. (Novocastra 1:200, &#xD7;400 magnification)</p></caption><graphic xlink:href="277_2012_1577_Fig1_HTML" id="MO1"/></fig></p>
    <p>In the World Health Organization classification, LCS is the malignant end of the spectrum of benign Langerhans cell histiocytosis (LCH) [<xref ref-type="bibr" rid="CR1">1</xref>]. The typical LCH cell is replaced by pleomorphic tumor cells in the LCS, only identifiable by phenotype or ultrastructure. Initial unifocal subcutaneous involvement is not unusual. However progressive disease, especially with multifocal dissemination, is highly fatal, despite multi-agent chemotherapy. It remains to be seen whether systemic progression may occur in our patient.</p>
    <p>Our patient demonstrated two hitherto unreported phenomena, namely paraneoplastic manifestation of LCS and acquired rampant disseminated lentigines as a new paraneoplastic dermatosis. The clinical history and histological findings do not suggest an underlying disseminated cutaneous LCH. Common paraneoplastic dermatoses (e.g., acanthocis nigricans) are well characterized and are putatively caused by neoplastic humoral secretions. Acquired melanocytic nevi are mostly related to solar exposure and are therefore localized. Recently, some cases of acral lentigines are debated to be paraneoplastic [<xref ref-type="bibr" rid="CR2">2</xref>]. Disseminated lentigines are usually only found in familial lentiginosis syndromes (e.g., LEOPARD syndrome, Peutz&#x2013;Jeghers, Carney complex, PTEN hamartoma syndrome). The neoplastic associations of these syndromes come from their primary systemic gene mutations [<xref ref-type="bibr" rid="CR3">3</xref>]. The rapidly acquired disseminated growth of lentigines in our case is highly unusual and is somewhat induced by the abnormal aggressive transformation of the LCS cells. Skin pigmentation is usually under exquisite humoral control [<xref ref-type="bibr" rid="CR4">4</xref>], and cutaneous Langerhans cells interact closely with melanocytes and keratinocytes [<xref ref-type="bibr" rid="CR5">5</xref>]. It is impossible, however, to retrospectively work out the exact mechanism how the localized growth induced a systemic pigment response, since interval archival specimens are unavailable and the list of possible mediators are extensive. In any case, extirpation of the primary lesion appeared to halt further skin lesions.</p>
  </body>
  <back>
    <ack>
      <sec id="d29e296">
        <title>Conflict of interest</title>
        <p>The authors declare that they have no conflict of interest.</p>
      </sec>
      <sec id="d29e301">
        <title>Open Access</title>
        <p>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Jaffe</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Facchetti</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Vardiman</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Extranodal NK/T-cell lymphoma, nasal type</article-title>
          <source>World Health Organization classfication of tumours of haematopoietic and lymphoid tissues</source>
          <year>2008</year>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC Press</publisher-name>
          <fpage>358</fpage>
          <lpage>360</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolf</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Orion</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Davidovici</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Acral lentigines: a new paraneoplastic syndrome</article-title>
          <source>Int J Dermatol</source>
          <year>2008</year>
          <volume>47</volume>
          <issue>2</issue>
          <fpage>168</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-4632.2008.03223.x</pub-id>
          <pub-id pub-id-type="pmid">18211490</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lodish</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Stratakis</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>The differential diagnosis of familial lentiginosis syndromes</article-title>
          <source>Familial cancer.</source>
          <year>2011</year>
          <volume>10</volume>
          <issue>3</issue>
          <fpage>481</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="doi">10.1007/s10689-011-9446-x</pub-id>
          <pub-id pub-id-type="pmid">21538076</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirobe</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes</article-title>
          <source>Pigment cell research</source>
          <year>2005</year>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>2</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0749.2004.00198.x</pub-id>
          <pub-id pub-id-type="pmid">15649147</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Facchetti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>de Wolf-Peeters</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>de Greef</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Desmet</surname>
              <given-names>VJ</given-names>
            </name>
          </person-group>
          <article-title>Langerhans cells in various benign and malignant pigment-cell lesions of the skin</article-title>
          <source>Arch Dermatol Res</source>
          <year>1984</year>
          <volume>276</volume>
          <issue>5</issue>
          <fpage>283</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00404618</pub-id>
          <pub-id pub-id-type="pmid">6237618</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
